IDEXX Labs (IDXX) Tops Q1 EPS by 64c, Updates Guidance

IDEXX Labs (NASDAQ: IDXX) reported Q1 EPS of $2.35, $0.64 better than the analyst estimate of $1.71. Revenue for the quarter came in at $778 million versus the consensus estimate of $738.43 million.

GUIDANCE:

IDEXX Labs sees FY2021 EPS of $7.88-$8.18, versus the consensus of $7.57. IDEXX Labs sees FY2021 revenue of $3.11-3.16 billion, versus the consensus of $3.09 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Pfizer lung cancer drug misses survival goal in Phase 3 trial